Salud financiera de hoja de balance de UBI Pharma
Salud financiera controles de criterios 4/6
UBI Pharma has a total shareholder equity of NT$1.2B and total debt of NT$92.5M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are NT$1.8B and NT$666.8M respectively. UBI Pharma's EBIT is NT$5.5M making its interest coverage ratio 0.9. It has cash and short-term investments of NT$340.3M.
Información clave
7.9%
Ratio deuda-patrimonio
NT$92.46m
Deuda
| Ratio de cobertura de intereses | 0.9x |
| Efectivo | NT$340.30m |
| Patrimonio | NT$1.17b |
| Total pasivo | NT$666.84m |
| Activos totales | NT$1.84b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 6562's short term assets (NT$680.4M) exceed its short term liabilities (NT$218.7M).
Pasivo a largo plazo: 6562's short term assets (NT$680.4M) exceed its long term liabilities (NT$448.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 6562 has more cash than its total debt.
Reducción de la deuda: 6562's debt to equity ratio has reduced from 85.7% to 7.9% over the past 5 years.
Cobertura de la deuda: 6562's debt is not well covered by operating cash flow (7.5%).
Cobertura de intereses: 6562's interest payments on its debt are not well covered by EBIT (0.9x coverage).